PatientsVille.com Logo

PatientsVille

Novorapid Side Effects

Common Novorapid Side Effects

The most commonly reported Novorapid side effects (click to view or check a box to report):

Hypoglycaemia (228)
Blood Glucose Increased (99)
Diabetes Mellitus Inadequate Control (94)
Hyperglycaemia (89)
Anti-insulin Antibody Positive (63)
Blood Glucose Fluctuation (55)
Suicide Attempt (50)
Anti-insulin Antibody Increased (45)
Intentional Overdose (44)
Hypoglycaemic Coma (44)
Anti-insulin Antibody (39)
Loss Of Consciousness (36)
Hepatic Function Abnormal (35)
Diabetic Ketoacidosis (34)
Premature Baby (31)
Malaise (29)
Alanine Aminotransferase Increased (27)
Aspartate Aminotransferase Increased (26)
Vomiting (26)
Dyspnoea (26)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Novorapid Side Effects Reported to FDA

The following Novorapid reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Novorapid on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Hypertension, Blood Glucose Abnormal, Exposure During Pregnancy
on Mar 03, 2014 Female from TR , 31 years of age, weighting 211.6 lb, was diagnosed with and was treated with Novorapid Flexpen. Directly after, patient experienced the unwanted or unexpected Novorapid side effects: hypertension, blood glucose abnormal, exposure during pregnancy. Novorapid Flexpen dosage: 38 U, Qd.
Associated medications used:
  • Levemir Flexpen (32 U, Qd)
  • Estrofem (1 Tab, Tid)
  • Folidoce (1 Df, Qd (1x1))
Patient was hospitalized.

Hospitalisation, Off Label Use
Patient was taking Novorapid Flexpen. Patient felt the following Novorapid side effects: hospitalisation, off label use on Feb 25, 2014 from ZA Additional patient health information: Male , 22 years of age, . Novorapid Flexpen dosage: Unk. Patient was hospitalized.

Abortion Spontaneous, Exposure During Pregnancy
Adverse event was reported on Feb 24, 2014 by a Female taking Novorapid Flexpen (Dosage: 24 U, Qd) was diagnosed with and. Location: TR , 33 years of age, weighting 224.9 lb, After Novorapid was administered, patient encountered several Novorapid side effects: abortion spontaneous, exposure during pregnancy.
Multiple concurrent drugs taken:
  • Insulatard Hm Penfill (10 U, Qd)
  • Folbiol (5 Mg, Qd)


Preterm Premature Rupture Of Membranes, Premature Delivery, Exposure During Pregnancy
on Mar 07, 2014 Female from JP , 32 years of age, was diagnosed with and was treated with Novorapid Chu. Directly after, patient experienced the unwanted or unexpected Novorapid side effects: preterm premature rupture of membranes, premature delivery, exposure during pregnancy. Novorapid Chu dosage: 3 U, Tid (3 Units Before Each Meal).


Convulsion
on Feb 20, 2014 Male from GB , 17 years of age, weighting 147.7 lb, was diagnosed with and was treated with Novorapid Flexpen. Patient felt the following Novorapid side effects: convulsion. Novorapid Flexpen dosage: Unk.
Multiple prescriptions taken:
  • Lamotrigine (Unk)
  • Gabapentin (Unk)
  • Midazolam (Unk)


Hypokalaemia
Patient was taking Novorapid Flexpen. After Novorapid was administered, patient encountered several Novorapid side effects: hypokalaemia on Feb 17, 2014 from IT Additional patient health information: Male , 57 years of age, was diagnosed with and. Novorapid Flexpen dosage: 29 U, Qd.
Multiple concurrent drugs taken:
  • Lasix /00032601/ (25 Mg, Qd)
  • Lantus (14 U, Qd)
  • Peptazol /01159001/
  • Tapazole
  • Ticlopidina
  • Adalat
  • Unipril /00574902/
  • Kanrenol
Patient was hospitalized.

Sepsis, Diabetic Ketoacidosis, Malaise, Hypoglycaemia, Diabetes Mellitus Inadequate Control, Blood Glucose Increased
Adverse event was reported on Mar 24, 2014 by a Female taking Novorapid Flexpen (Dosage: 6 U, Tid ( 8am / 12pm / 8pm )) was diagnosed with and. Location: GB , 74 years of age, weighting 132.3 lb, Directly after, patient experienced the unwanted or unexpected Novorapid side effects: sepsis, diabetic ketoacidosis, malaise, hypoglycaemia, diabetes mellitus inadequate control, blood glucose increased. Patient was hospitalized.

Subdural Haematoma, Hypoglycaemia
on Feb 07, 2014 Male from FR , 75 years of age, was diagnosed with and was treated with Novorapid. Patient felt the following Novorapid side effects: subdural haematoma, hypoglycaemia. Novorapid dosage: Unk (6-8 Iu In The Morning And 8-12 Iu At Noon).
Multiple prescriptions taken:
  • Lantus (20 Iu, Qd (evening))
Patient was hospitalized.

Haemolytic Anaemia
on Feb 07, 2014 Male from FR , 50 years of age, was treated with Novorapid. After Novorapid was administered, patient encountered several Novorapid side effects: haemolytic anaemia. Novorapid dosage: Unk.
Multiple concurrent drugs taken:
  • Prograf (Unk)
  • Rovalcyte (Unk)
  • Inexium /01479302/ (80 Mg, Qd)
  • Prednisone (Unk)
  • Cellcept /01275102/ (Unk)
  • Neoral (Unk)
Patient was hospitalized.

Alanine Aminotransferase Increased, Intentional Overdose
Patient was taking Novorapid. Directly after, patient experienced the unwanted or unexpected Novorapid side effects: alanine aminotransferase increased, intentional overdose on Feb 04, 2014 from GB Additional patient health information: Male , 56 years of age, was diagnosed with and. Novorapid dosage: 500 U, Single.
Associated medications used:
  • Lantus (30 U, Qd)
  • Lantus (140 U, Single)
Patient was hospitalized.

Hypersensitivity, Blood Glucose Increased
Adverse event was reported on Mar 14, 2014 by a Female taking Novorapid Penfill (Dosage: 18 U, Qd (3x6 Units)) was diagnosed with and. Location: BG , 40 years of age, weighting 156.5 lb, Patient felt the following Novorapid side effects: hypersensitivity, blood glucose increased. Patient was hospitalized.

Viral Infection, Application Site Haematoma
on Feb 05, 2014 Male from BR , weighting 132.3 lb, was diagnosed with and was treated with Novorapid Flexpen. After Novorapid was administered, patient encountered several Novorapid side effects: viral infection, application site haematoma. Novorapid Flexpen dosage: 14 To 15 Iu, 6 Times Daily. Patient was hospitalized.

Suicide Attempt, Intentional Overdose, Hypoglycaemic Unconsciousness
on Jan 31, 2014 Female from GB , 53 years of age, was diagnosed with and was treated with Novorapid Penfill. Directly after, patient experienced the unwanted or unexpected Novorapid side effects: suicide attempt, intentional overdose, hypoglycaemic unconsciousness. Novorapid Penfill dosage: 6 U, Tid (approx 6 Units Per Meal=18 Units Total Daily).
Associated medications used:
  • Insulatard (Unk)
  • Fluoxetine (Unk)
  • Fluoxetine
Patient was hospitalized.

Renal Failure Acute
Patient was taking Novorapid. Patient felt the following Novorapid side effects: renal failure acute on Jan 08, 2014 from FR Additional patient health information: Male , 80 years of age, was diagnosed with and. Novorapid dosage: One Dose.
Multiple prescriptions taken:
  • Clamoxyl (amoxicillin) (3 G, Qid)
  • Clamoxyl (amoxicillin) (12 G, Qd)
Patient was hospitalized.

Abortion Spontaneous, Exposure During Pregnancy
Adverse event was reported on Jan 07, 2014 by a Female taking Novorapid Flexpen (Dosage: 12 U, Qd) was diagnosed with and. Location: TR , 34 years of age, weighting 187.4 lb, After Novorapid was administered, patient encountered several Novorapid side effects: abortion spontaneous, exposure during pregnancy.
Multiple concurrent drugs taken:
  • Levemir Flexpen (8 U, Qd)
  • Alfamet (250 Mg, Tid)


Cardiac Failure, Diabetes Mellitus Inadequate Control, Hypoglycaemia
on Jan 03, 2014 Patient from JP , 65 years of age, was diagnosed with and was treated with Novorapid Chu Flexpen. Directly after, patient experienced the unwanted or unexpected Novorapid side effects: cardiac failure, diabetes mellitus inadequate control, hypoglycaemia. Novorapid Chu Flexpen dosage: 160 Iu, Qd. Patient was hospitalized.

Suicide Attempt, Intentional Overdose, Hypoglycaemia
on Dec 30, 2013 Female from JP , 86 years of age, was diagnosed with and was treated with Novorapid 30 Mix Chu Flexpen. Patient felt the following Novorapid side effects: suicide attempt, intentional overdose, hypoglycaemia. Novorapid 30 Mix Chu Flexpen dosage: Unk. Patient was hospitalized.

Infection, Blood Glucose Increased
Patient was taking Novorapid. After Novorapid was administered, patient encountered several Novorapid side effects: infection, blood glucose increased on Dec 30, 2013 from GB Additional patient health information: Female , 34 years of age, was diagnosed with and. Novorapid dosage: Carbohydrate Counting.
Multiple concurrent drugs taken:
  • Lantus (22 U At Morning)
Patient was hospitalized.

Incorrect Dose Administered
Adverse event was reported on Dec 23, 2013 by a Female taking Novorapid Penfill (Dosage: Unk) . Location: BR , 19 years of age, Directly after, patient experienced the unwanted or unexpected Novorapid side effects: incorrect dose administered.
Associated medications used:
  • Lantus


Suicide Attempt, Intentional Overdose
on Dec 20, 2013 Female from AU , 23 years of age, was treated with Novorapid Flexpen. Patient felt the following Novorapid side effects: suicide attempt, intentional overdose. Novorapid Flexpen dosage: 6 U, Tid (usually On 6 Units).
Multiple prescriptions taken:
  • Insulin Glargine
Patient was hospitalized.

Respiratory Arrest, Overdose, Hypoglycaemia, Convulsion, Hyperglycaemia
on Dec 13, 2013 Female from IT , 69 years of age, was diagnosed with and was treated with Novorapid Flexpen. After Novorapid was administered, patient encountered several Novorapid side effects: respiratory arrest, overdose, hypoglycaemia, convulsion, hyperglycaemia. Novorapid Flexpen dosage: 20 U, Tid (60 U Qd). Patient was hospitalized.

Hypoglycaemia
Patient was taking Novorapid. Directly after, patient experienced the unwanted or unexpected Novorapid side effects: hypoglycaemia on Jan 30, 2014 from FR Additional patient health information: Female , 19 years of age, was diagnosed with and. Novorapid dosage: 32 Iu, Qd.
Associated medications used:
  • Insulatard (8 Iu, Qid (8 Iu Four Times Daily))
  • Levocarnil (6 Df, Qd (6 Pharmaceutical Doses Daily))
  • Zelitrex (500 Mg)
  • Beflavine (10 Mg)
  • Levothyrox (75 ?g, Qd)
Patient was hospitalized.

Premature Baby, Poor Sucking Reflex, Vomiting Neonatal
Adverse event was reported on Dec 09, 2013 by a Female taking Novorapid Flexpen (Dosage: 9 U, Qd) was diagnosed with and. Location: TR , weighting 5.69 lb, Patient felt the following Novorapid side effects: premature baby, poor sucking reflex, vomiting neonatal. Patient was hospitalized.

Suicide Attempt, Intentional Overdose, Hypoglycaemia
on Jan 03, 2014 Female from JP , 47 years of age, was diagnosed with and was treated with Novorapid Chu. After Novorapid was administered, patient encountered several Novorapid side effects: suicide attempt, intentional overdose, hypoglycaemia. Novorapid Chu dosage: 600 Iu, Qd.
Multiple concurrent drugs taken:
  • Lendormin (15 Mg, Single (60 Tablets Of 0.25mg Orally))
Patient was hospitalized.

Vaginal Haemorrhage, Pregnancy
on Dec 06, 2013 Female from TR , weighting 154.3 lb, was diagnosed with and was treated with Novorapid Flexpen. Directly after, patient experienced the unwanted or unexpected Novorapid side effects: vaginal haemorrhage, pregnancy. Novorapid Flexpen dosage: 24 U, Qd.
Associated medications used:
  • Elevit /01730301/ (1 Per Day)
  • Ferrosanol (1 Caps, Qd)


1 of 46 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Novorapid Side Effects

    Did You Have a Novorapid Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Novorapid for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    More About Novorapid

    Side Effects reported to FDA: 1139

    Novorapid safety alerts: No

    Reported deaths: 21

    Reported hospitalizations: 244

    Latest Novorapid clinical trials